Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins

Gene Therapy

Volumn 8, Issue 15, 2001, Pages 1202-1206

  Engelstadter M ^a   Buchholz, C J ^a   Bobkova, M ^a   Steidl, S ^a   Merget Millitzer, H ^a   Willemsen, R A ^b   Stitz, J ^a   Cichutek, K ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gene therapy; Pseudotyping; Retroviral vector; T cells; Targeting

Indexed keywords

ANTIBODY; COMPLEMENT; MEMBRANE PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ARTICLE; CELL LINE; CLASSIFICATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOPLASM; DNA MODIFICATION; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNITY; IN VIVO STUDY; LYMPHOCYTE; MURINE LEUKEMIA VIRUS; NONHUMAN; PACKAGING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; SPLEEN NECROSIS ONCOVIRUS; T LYMPHOCYTE; VIRUS INFECTION; VIRUS PARTICLE;

ANIMALS; CELL LINE; DOGS; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; RETROVIRIDAE; TRANSFECTION;

EID: 0034882342     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301500     Document Type: Article

References (26)

1. Retroviral cell targeting vectors
2. Targeting retrovirus entry
3. Retroviral retargeting by envelopes expressing an N-terminal binding domain
4. Retrovirus targeting by tropism restriction to melanoma cells
5. Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyse virus-cell fusion
6. Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors
7. In vivo selection of protease cleavage sites from retrovirus display libraries
8. Toward highly efficient cell-type-specific gene-transfer with retroviral vectors displaying single-chain antibodies
9. Cell-type specific gene transfer into human cells with retroviral vectors that display single-chain antibodies
10. Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library
11. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell
12. High-titer packaging cells producing recombinant retroviruses resistant to human serum
13. Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum
14. The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent
15. Reticuloendotheliosis type C and primate type D oncoretroviruses are members of the same receptor interference group
16. Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells
17. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
18. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients
19. A transient three-plasmid expression system for the production of high titer retroviral vectors
20. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry
21. MLV-derived retroviral pseudotype vectors
22. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells
23. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins
24. A hyperfusogenic gibbon are leukemia envelope glycoprotein: Targeting of a cytotoxic gene by ligand display
25. Improved retroviral packaging cell lines derived from spleen necrosis virus
26. Monoclonal antibodies against avian reticuloendotheliosis virus: Identification of strain-specific and strain-common epitopes